🔥🐔 BizChicken 🐔🔥

Learn About the Corporations Around You

Sign Up Today!

Sign up for BizChicken and discover more about the corporations around you.

Neumora Therapeutics, Inc. Common Stock

Neumora Therapeutics, Inc. Common Stock logo
Market Cap: High
Employees: Low

navacaprant (NMRA-140)

Neumora Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing therapeutic treatments for brain diseases, neuropsychiatric disorders, and neurodegenerative diseases. Key programs include navacaprant for major depressive disorder, and several promising treatments in various stages of clinical and preclinical trials targeting conditions such as Alzheimer's, schizophrenia, and Parkinson's disease.

Tags: biopharmaceutical, brain diseases, clinical trials, neurodegenerative diseases, neuropsychiatric disorders

Symbol: NMRA

Recent Price: $11.06

Industry: Biotechnology

CEO: Mr. Henry O. Gosebruch

Sector: Healthcare

Employees: 108

Address: 490 Arsenal Way, Watertown, null 02472

Phone: 857 760 0900

Last updated: 2024-12-31